SCHEMBL24966743

SCHEMBL24966743

C=CCOC(=O)c1c(F)nnn1[C@H](C)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.43
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
ALDH1A1 P00352 2/20 0.39
TSHR P16473 1/20 0.39
HSD17B10 Q99714 1/20 0.39
GABRA1 P14867 3/20 0.37
GABRB2 P47870 3/20 0.37
CYP1A2 P05177 2/20 0.37
CYP11B1 P15538 2/20 0.37
CYP11B2 P19099 2/20 0.37
LMNA P02545 2/20 0.37
GABRA2 P47869 2/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
ABCB11 O95342 1/20 0.37
MAPK1 P28482 2/20 0.36
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24966093 0.87 CYP3A4 (0.42) CYP3A4MEN1KMT2AALDH1A1TSHR
SCHEMBL24966821 0.87 CYP3A4 (0.42) CYP3A4MEN1KMT2AALDH1A1TSHR
SCHEMBL24966776 0.85 CYP1A2 (0.51) CYP3A4ALDH1A1TSHRHSD17B10GABRA1
SCHEMBL24966734 0.83 PDCD1 (0.40) CYP3A4MEN1KMT2AALDH1A1GABRA1
SCHEMBL24967325 0.82 ATM (0.32) ALDH1A1MAPK1BRD4
SCHEMBL24966836 0.81 CARM1 (0.40) CYP3A4GABRA1GABRB2CYP1A2CYP11B1
SCHEMBL24966943 0.80 GABRA1 (0.46) CYP3A4MEN1KMT2AALDH1A1TSHR
SCHEMBL24966779 0.80 ALDH1A1 (0.42) MEN1KMT2AALDH1A1HSD17B10LMNA
SCHEMBL23234260 0.80 ALDH1A1 (0.42) MEN1KMT2AALDH1A1HSD17B10LMNA
SCHEMBL24966194 0.79 BRD4 (0.40) MEN1KMT2AALDH1A1HSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230026724-A1 SUBSTITUTED NITROGEN HETEROCYCLIC COMPOUND AND ANESTHETIC EFFECT THEREOF CHENGDU MFS PHARMA. CO., LTD. (CN) 2023-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230026724-A1 SUBSTITUTED NITROGEN HETEROCYCLIC COMPOUND AND ANESTHETIC EFFECT THEREOF CYP21A2, CYP11B1, CYP11B2 CYP3A4 8/4885MEN1 2865/4885KMT2A 1478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.